$2.35
-0.26-9.98%
Last update: Nov 2, 6:26 PM
Pacific Biosciences of California Inc (PACB) Stock Price, Quote, News & History
PACBNASDAQ
U.S. stocks mixed; Dow gained ~100 points. Vertiv jumped 13.3% on strong results and raised guidance; Ultralife soared 145.8% on buyout news.
You can purchase shares of Pacific Biosciences (NASDAQ:PACB) through any online brokerage.
Other companies in Pacific Biosciences’s space includes: Thermo Fisher Scientific Inc (NYSE:TMO), Danaher Corp (NYSE:DHR), Agilent Technologies Inc (NYSE:A), Waters Corp (NYSE:WAT) and IQVIA Holdings Inc (NYSE:IQV).
Pacific Biosciences has a consensus price target of $2.30.
The stock price for Pacific Biosciences (NASDAQ: PACB) is $2.334 last updated November 2, 2026 at 6:26 PM EST.
There are no upcoming dividends for Pacific Biosciences.
Pacific Biosciences does not have any upcoming earnings scheduled.
There is no upcoming split for Pacific Biosciences.
Pacific Biosciences is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately,...
